Suppr
超能文献

IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum.

作者信息

Yadav Rashi, Vague Morgan, Rettig Malia, Loo Christopher P, Brown Kasidy, Samiea Abrar, Moreau Joshua M, Ortega-Loayza Alex G

机构信息

Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, Oregon, USA.

Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

J Invest Dermatol. 2025 May;145(5):1209-1212.e3. doi: 10.1016/j.jid.2024.08.040. Epub 2024 Oct 10.

DOI:10.1016/j.jid.2024.08.040

PMID:39393505

Abstract

摘要

相似文献

IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum.

J Invest Dermatol. 2025 May;145(5):1209-1212.e3. doi: 10.1016/j.jid.2024.08.040. Epub 2024 Oct 10.

IL-12/IL23 blockade reveals patterns of asynchronous inflammation in pyoderma gangrenosum.

bioRxiv. 2024 Apr 29:2024.04.26.591387. doi: 10.1101/2024.04.26.591387.

Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.

SAGE Open Med Case Rep. 2019 May 2;7:2050313X19845206. doi: 10.1177/2050313X19845206. eCollection 2019.

Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.

Australas J Dermatol. 2018 May;59(2):131-134. doi: 10.1111/ajd.12744. Epub 2017 Dec 4.

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24.

The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial.

J Invest Dermatol. 2025 Jun;145(6):1396-1406.e6. doi: 10.1016/j.jid.2024.10.602. Epub 2024 Nov 14.

Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

Am J Clin Dermatol. 2018 Aug;19(4):479-487. doi: 10.1007/s40257-018-0356-7.

Nodular Scleritis and Pyoderma Gangrenosum Associated with Active Ulcerative Colitis: A Case Report.

Case Rep Ophthalmol. 2025 Jun 10;16(1):475-481. doi: 10.1159/000546828. eCollection 2025 Jan-Dec.

Ustekinumab for pyoderma gangrenosum-like skin ulcerations in late-onset leukocyte adhesion deficiency.

J Allergy Clin Immunol Glob. 2024 Feb 29;3(2):100233. doi: 10.1016/j.jacig.2024.100233. eCollection 2024 May.

Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.

Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.

引用本文的文献

Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures.

Immunol Rev. 2025 Sep;334(1):e70059. doi: 10.1111/imr.70059.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum.

J Invest Dermatol. 2025 May;145(5):1209-1212.e3. doi: 10.1016/j.jid.2024.08.040. Epub 2024 Oct 10.

IL-12/IL23 blockade reveals patterns of asynchronous inflammation in pyoderma gangrenosum.

bioRxiv. 2024 Apr 29:2024.04.26.591387. doi: 10.1101/2024.04.26.591387.

Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.

SAGE Open Med Case Rep. 2019 May 2;7:2050313X19845206. doi: 10.1177/2050313X19845206. eCollection 2019.

Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.

Australas J Dermatol. 2018 May;59(2):131-134. doi: 10.1111/ajd.12744. Epub 2017 Dec 4.

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24.

The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial.

J Invest Dermatol. 2025 Jun;145(6):1396-1406.e6. doi: 10.1016/j.jid.2024.10.602. Epub 2024 Nov 14.

Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

Am J Clin Dermatol. 2018 Aug;19(4):479-487. doi: 10.1007/s40257-018-0356-7.

Nodular Scleritis and Pyoderma Gangrenosum Associated with Active Ulcerative Colitis: A Case Report.

Case Rep Ophthalmol. 2025 Jun 10;16(1):475-481. doi: 10.1159/000546828. eCollection 2025 Jan-Dec.

Ustekinumab for pyoderma gangrenosum-like skin ulcerations in late-onset leukocyte adhesion deficiency.

J Allergy Clin Immunol Glob. 2024 Feb 29;3(2):100233. doi: 10.1016/j.jacig.2024.100233. eCollection 2024 May.

Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.

Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.

引用本文的文献

Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures.

Immunol Rev. 2025 Sep;334(1):e70059. doi: 10.1111/imr.70059.

Suppr超能文献

IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译